ArticlePLOS digital health2025
CombiANT reader: Deep learning-based automatic image processing tool to robustly quantify antibiotic interactions.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reclaiming the Microbial Battlefield: Adjuvant Strategies to Overcome Antibiotic Resistance.Microorganisms · 2026Review
- Advancements in AI-driven drug sensitivity testing research.Frontiers in cellular and infection microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic resistance is a severe danger to human health, and combination therapy with several antibiotics has emerged as a viable treatment option for multi-resistant strains. CombiANT is a recently developed agar plate-based assay where three reservoirs on the bottom of the plate create a diffusion landscape of three antibiotics that allows testing of the efficiency of antibiotic combinations. This test, however, requires manually assigning nine reference points to each plate, which can be prone to errors, especially when plates need to be graded in large batches and by different users. In this study, an automated deep learning-based image processing method is presented that can accurately segment bacterial growth and measure distances between key points on the CombiANT assay at sub-millimeter precision. The software was tested on 100 plates using photos captured by three different users with their mobile phone cameras, comparing the automated analysis with the human scoring. The result indicates significant agreement between the users and the software ([Formula: see text] mm mean absolute error) and remains consistent when applied to different photos of the same assay despite varying photo qualities and lighting conditions. The speed and robustness of the automated analysis could streamline clinical workflows and make it easier to tailor treatment to specific infections. It could also aid large-scale antibiotic research by quickly processing hundreds of experiments in batch, obtaining better data, and ultimately supporting the development of better treatment strategies. The software can easily be integrated into a potential smartphone application, making it accessible in resource-limited environments. Integrating deep learning-based smartphone image analysis with simple agar-based tests like CombiANT could unlock powerful tools for combating antibiotic resistance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.